Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07112287
NA
Germline Testing for Predisposition to Myeloid Malignancies
Sponsor: Christopher Reilly
View on ClinicalTrials.gov
Summary
The goal of this research study is to evaluate the feasibility of germline genetic testing using the investigational MyeloGen Gene Panel in adult participants diagnosed with myeloid malignancies.
Official title: MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2026-02
Completion Date
2033-04-01
Last Updated
2025-08-08
Healthy Volunteers
No
Interventions
DEVICE
MyeloGen Gene Panel
The MyeloGen Gene Panel is investigational Germline genetic testing using skin fibroblasts.
Locations (1)
Dana-Farber Cancer Institute
Boston, Massachusetts, United States